Company / Operating Cash Flow
iBio, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$18.6M
FY2025
5-year range
-$37.5M / -$13.3M
FY2021-FY2025
Trend
+39.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$37M in FY2023 to -$5M in FY2016.
Based on SEC 10-K filings.
-$19M in FY2025.
Improved from -$37M to -$19M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 39.0% year-over-year.
- Peak operating cash flow was recorded in FY2016.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$18.6M | +39.0% |
| FY2024 | -$30.4M | +18.8% |
| FY2023 | -$37.5M | -24.7% |
| FY2022 | -$30.1M | -125.3% |
| FY2021 | -$13.3M | +4.5% |
| FY2020 | -$14.0M | -3.7% |
| FY2019 | -$13.5M | -2.4% |
| FY2018 | -$13.2M | -63.1% |
| FY2017 | -$8.1M | -70.8% |
| FY2016 | -$4.7M | -14.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026